Abstract:OBJECTIVE:To investigate the roles of peroxiredoxin (Prdx) 6 in the regulation of oxidative stress to lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice.METHODS:Prdx6 knockout mice were tested for their genotype by PCR and Prdx6 protein expression was measured in lungs by immunohistochemistry. Eighteen male Prdx6 knockout mice were randomised to the Prdx6 knockout control group and the Prdx6 knockout LPS 24 h group, with 9 mice in each group. Eighteen male wild-type C57BL/6J mice were randomised to the wild-type control group and the wild-type LPS 24 h group, with 9 mice in each group. ALI was induced by intratracheal administration of 5mg/kg LPS. Twenty-four hours after stimulation, lung tissue slides were stained with hematoxylin and eosin for histological evaluation. The concentration of protein in the bronchial alveolar lavage fluid (BALF) was measured by using the Micro BCA Protein Assay Kit. Levels of reactive oxygen species (ROS) in the lungs were quantified by measurement of hydrogen peroxide (H(2)O(2)). Lipid and protein peroxidation were measured as levels of malondialdehyde (MDA) and protein carbonylation. H(2)O(2), MDA, protein carbonyl, total superoxide dismutase (SOD) activity, and total antioxidative capacity (TAOC) in lungs were measured by using assay kits from the manufacture.RESULTS:Prdx6 knockout mice presented their genotype and there was no Prdx6 protein expression in the lung. Increased polymorphonuclear cells in alveoli and bronchial wall thickening were observed in the lungs of LPS groups, which were more severe in Prdx6 knockout LPS 24 h group compared with wild-type LPS 24 h group. LPS instillation induced a significant elevated protein concentration in BALF in wild-type LPS 24 h group (441 ± 54) mg/L compared with wild-type control group (168 ± 20) mg/L (t = -4.71, P < 0.01). Significantly increased protein level in BALF was observed in Prdx6 knockout LPS 24 h group (770 ± 66) mg/L compared with wild-type LPS 24 h group (t = -3.69, P < 0.01). LPS instillation induced a significantly decreased SOD activity in wild-type LPS 24 h group (16.0 ± 1.2) U/mg protein compared with wild-type control group (26.5 ± 3.9) U/mg protein (t = 6.22, P < 0.01). SOD activity in Prdx6 knockout LPS 24 h group (14.5 ± 5.3) U/mg protein was not statistical different from wild-type LPS 24 h group (t = 0.56, P = 0.60). LPS instillation induced a significantly increased H(2)O(2) and MDA in wild-type LPS 24 h group [H(2)O(2)(52.3 ± 7.8) nmol/g protein; MDA (3.3 ± 0.5) nmol/mg protein] compared with wild-type control group [H(2)O(2)(29.5 ± 3.2) nmol/g protein, (t = -4.25, P < 0.01); MDA (1.6 ± 0.8) nmol/mg protein, (t = -5.94, P < 0.01)]. Significantly increased H(2)O(2) and MDA [H(2)O(2)(73.5 ± 12.4) nmol/g protein, (t = -3.01, P = 0.02); MDA (5.9 ± 0.9) nmol/mg protein, (t = -6.01, P < 0.01)] were observed in Prdx6 knockout LPS 24 h group compared with wild-type LPS 24 h group. No significant difference of protein carbonylation was observed in wild-type LPS 24 h group (6.9 ± 1.2) nmol/mg protein compared with wild-type control group (6.1 ± 0.9) nmol/mg protein (t = -1.62, P = 0.15). Significantly increased protein carbonylation (8.9 ± 0.9) nmol/g protein was observed in Prdx6 knockout LPS 24 h group compared with wild-type LPS 24 h group (t = -2.76, P = 0.03). LPS instillation induced a significantly decreased TAOC in wild-type LPS 24 h group (4.7 ± 0.6) U/mg protein compared with wild-type control group (6.5 ± 0.4) U/mg protein (t = 3.35, P < 0.01). Significantly decreased TAOC was observed in Prdx6 knockout LPS 24 h group (3.9 ± 0.4)U/mg protein compared with wild-type LPS 24 h group (t = 2.44, P = 0.04). The above parameters were not statistically different between Prdx6 knockout control group and wild-type control group.CONCLUSION:Deletion of peroxiredoxin 6 exaggerated LPS-induced acute lung injury with increased oxidative stress.

Peroxiredoxin 6 attenuates lipopolysaccharide-induced plasminogen activatro inhibitor 1 expression by regulating autophagy

Time‑dependent changes in NLRP3 and Nrf2 levels in lipopolysaccharide‑induced acute lung injury

Phosphodiesterase 4B is Required for NLRP3 Inflammasome Activation by Positive Feedback with Nrf2 in the Early Phase of LPS- Induced Acute Lung Injury

[Roles of Peroxiredoxin 6 in the Regulation of Oxidative Stress to Lipopolysaccharide-Induced Acute Lung Injury].

Deletion of peroxiredoxin 6 potentiates lipopolysaccharide-induced acute lung injury in mice.

Plasminogen Activator Inhibitor-1 Regulates LPS Induced Inflammation in Rat Macrophages Through Autophagy Activation.

Plasminogen Activator Inhibitor-1 Regulates LPS-Induced TLR4/MD-2 Pathway Activation and Inflammation in Alveolar Macrophages

Critical Roles of PAI-1 in Lipopolysaccharide-Induced Acute Lung Injury.

Peroxiredoxin 6 Knockout Aggravates Cecal Ligation and Puncture-Induced Acute Lung Injury.

Plasminogen Activator Inhibitor Type-1 Deficiency Exaggerates Lps-Induced Acute Lung Injury Through Enhancing Toll-Like Receptor 4 Signaling Pathway

Proteomic Analysis of Lung Tissue in a Rat Acute Lung Injury Model: Identification of PRDX1 as a Promoter of Inflammation

Both Peroxidase and Phospholipase A2 Activities of peroxiredoxin 6 Protect Against Oxidative Stress by Reduction of Peroxidized Cell Membranes

Alarmin Hnp-1 Promotes Pyroptosis And Il-1 Beta Release Through Different Roles Of Nlrp3 Inflammasome Via P2x7 In Lps-Primed Macrophages

Protective effects of peroxiredoxin 6 in modeling proinflammatory response using RAW 264.7 macrophages

Knockdown of phosphoinositide-dependent kinase 1 (PDK1) inhibits fibrosis and inflammation in lipopolysaccharide-induced acute lung injury rat model by attenuating NF-κB/p65 pathway activation

Hepatocytes-derived Prdx1 regulates macrophage phenotypes via TLR4 activation in acute liver injury

Peroxiredoxin 6 Differentially Regulates Acute and Chronic Cigarette Smoke–mediated Lung Inflammatory Response and Injury

Protective Effects of Peroxiredoxin 6 in Pro-Inflammatory Response Model Using Raw 264.7 Macrophages

Protectin D1 promotes resolution of inflammation in a murine model of lipopolysaccharide-induced acute lung injury via enhancing neutrophil apoptosis

Peroxiredoxin 6 suppresses Muc5ac overproduction in LPS-induced airway inflammation through H 2 O 2 -EGFR-MAPK signaling pathway.

Plumbagin ameliorates LPS‐induced acute lung injury by regulating PI3K/AKT/mTOR and Keap1‐Nrf2/HO‐1 signalling pathways